SMAD7 enhances adult β-cell proliferation without significantly affecting β-cell function in mice
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 295 (15) , 4858-4869
Abstract
No abstract availableKeywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (RO1DK111460)
This publication has 45 references indexed in Scilit:
- Increased Yield and Improved Transplantation Outcome of Mouse Islets with Bovine Serum AlbuminJournal of Transplantation, 2012
- MafA and MafB activity in pancreatic β cellsTrends in Endocrinology & Metabolism, 2011
- Developmental biology of the pancreas: A comprehensive reviewDevelopmental Biology, 2009
- Phospho-control of TGF-β superfamily signalingCell Research, 2008
- TGF-β isoform signaling regulates secondary transition and mesenchymal-induced endocrine development in the embryonic mouse pancreasDevelopmental Biology, 2007
- Developmental and adult phenotyping directly from mutant embryonic stem cellsProceedings of the National Academy of Sciences, 2007
- Conditional Expression of Smad7 in Pancreatic β Cells Disrupts TGF-β Signaling and Induces Reversible Diabetes MellitusPLOS Biology, 2006
- The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene, 1999
- TGF-β stimulation and inhibition of cell proliferation: New mechanistic insightsCell, 1990
- Effects of Hemipancreatectomy on Insulin Secretion and Glucose Tolerance in Healthy HumansNew England Journal of Medicine, 1990